MBX Capital — 2023 Investments

2 investments dated 2023 · listed companies and verified rows first · show all

Macro Trialsmacrotrials.com inSeed · Jun 2023 · $6M

Macro Trials optimizes clinical trial enrollment by connecting research sponsors with eye care practices and patients, enabling efficient trials with reliable data collection and patient access to new treatments through trusted local providers.

BiotechDigital HealthHealthtechMedical Devices

Jon Cabin, M.D.(Co-Founder and Chief Medical Officer)Jon Cabin(Co-Founder and Chief Medical Officer)Brooke LeVasseur(President & Chief Executive Officer)

Co-investorsHealthy Ventures Initiate Venture Partners Inflect Health

Persist AIpersist-ai.com inApr 2023

Persist AI provides AI-driven formulation development services for pharmaceutical compounds, combining robotic lab automation with machine learning models to accelerate drug formulation optimization and reduce time-to-market.

AI & Machine LearningBiotechHealthtechMedical DevicesRoboticsSacramento, US

Karthik Raman(Founder)inChristopher Shelner(Founder)in

Co-investors2048 Ventures Global Brain Good AI Capital Jovono Pioneer Spero Ventures +5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.